US Stock MarketDetailed Quotes

VSEEW VSEE HEALTH INC C/WTS 24/04/2029 (TO PUR COM)

Watchlist
  • 0.131
  • +0.031+31.04%
Close Aug 2 16:00 ET
  • 0.131
  • 0.000-0.23%
Post 19:57 ET
0Market Cap0.00P/E (TTM)

VSEE HEALTH INC C/WTS 24/04/2029 (TO PUR COM) Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2022
(FY)Dec 31, 2021
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
579.29K
-79.60%-825.81K
-459.8K
Net income from continuing operations
--29.17K
-432.73%-925.75K
--278.23K
Operating gains losses
----
--64.73K
----
Depreciation and amortization
--618
----
----
Other non cash items
--7K
112.00%15.96K
---133.08K
Change In working capital
--533.3K
100.69%4.15K
---604.96K
-Change in receivables
---8.12K
-131.77%-118.49K
--372.95K
-Change in prepaid assets
---22.41K
105.45%5.56K
---101.94K
-Change in payables and accrued expense
---5.18K
711.26%664.96K
---108.79K
-Change in other working capital
--569K
28.58%-547.88K
---767.17K
Cash from discontinued investing activities
Operating cash flow
--579.29K
-79.59%-825.78K
---459.8K
Investing cash flow
Cash flow from continuing investing activities
-8.74K
Net PPE purchase and sale
---8.74K
----
----
Cash from discontinued investing activities
Investing cash flow
---8.74K
----
----
Financing cash flow
Cash flow from continuing financing activities
0
2,190.32%710K
31K
Net issuance payments of debt
--0
--710K
--0
Net common stock issuance
----
--0
--31K
Cash from discontinued financing activities
Financing cash flow
--0
2,190.32%710K
--31K
Net cash flow
Beginning cash position
--118.73K
-55.31%346.44K
--775.24K
Current changes in cash
--570.55K
73.00%-115.78K
---428.8K
End cash Position
--689.28K
-33.42%230.66K
--346.44K
Free cash flow
--570.55K
-79.59%-825.78K
---459.8K
Currency Unit
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
(Q1)Mar 31, 2024(FY)Dec 31, 2022(FY)Dec 31, 2021
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 579.29K-79.60%-825.81K-459.8K
Net income from continuing operations --29.17K-432.73%-925.75K--278.23K
Operating gains losses ------64.73K----
Depreciation and amortization --618--------
Other non cash items --7K112.00%15.96K---133.08K
Change In working capital --533.3K100.69%4.15K---604.96K
-Change in receivables ---8.12K-131.77%-118.49K--372.95K
-Change in prepaid assets ---22.41K105.45%5.56K---101.94K
-Change in payables and accrued expense ---5.18K711.26%664.96K---108.79K
-Change in other working capital --569K28.58%-547.88K---767.17K
Cash from discontinued investing activities
Operating cash flow --579.29K-79.59%-825.78K---459.8K
Investing cash flow
Cash flow from continuing investing activities -8.74K
Net PPE purchase and sale ---8.74K--------
Cash from discontinued investing activities
Investing cash flow ---8.74K--------
Financing cash flow
Cash flow from continuing financing activities 02,190.32%710K31K
Net issuance payments of debt --0--710K--0
Net common stock issuance ------0--31K
Cash from discontinued financing activities
Financing cash flow --02,190.32%710K--31K
Net cash flow
Beginning cash position --118.73K-55.31%346.44K--775.24K
Current changes in cash --570.55K73.00%-115.78K---428.8K
End cash Position --689.28K-33.42%230.66K--346.44K
Free cash flow --570.55K-79.59%-825.78K---459.8K
Currency Unit USDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAP

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg